Effective January 1, 2024, the Centers for Medicare & Medicaid Services (CMS) has created a New Technology Healthcare Common Procedure Coding System (HCPCS) procedure code for hospital outpatient departments and ambulatory surgical centers to report for procedures involving the TriNav® Infusion System.
Reimbursement Information for the TriNav® Infusion System
This new code, HCPCS C9797, has been assigned to the Ambulatory Payment Classification (APC) 5194 – Level 4 Endovascular Procedures.
Reimbursement Support
For more information, contact TriNav Reimbursement Support at reimbursement@TriSalusLifeSci.com.
- Physician and hospital coding assistance
- Overview of payment methodologies
- Hospital-specific payment calculations for Medicare
- Reimbursement questions specific to TriNav, including commercial coverage
- Proactive reimbursement onboarding
Questions about reimbursement?
Contact one of our experts.
The coding information provided is general in nature, gathered from third-party sources and subject to change without notice. The provider is solely responsible for determining medical necessity, the appropriate setting for service delivery, and submitting accurate claims for products and services rendered. TriSalus encourages facilities to contact payers for specific information on their coding, coverage and payment policies.
Let us tell you more.
Contact us to learn more about this improved technology for the proprietary PEDD approach.
Rx Only. For the safe and proper use of the TriNav device, refer to the Instructions for Use.
Indications for Use: The TriNav Infusion System is intended for use in angiographic procedures. It delivers radiopaque media and therapeutic agents to selected sites in the peripheral vascular system.1
Contraindications: TriNav is not intended for use in the vasculature of the central nervous system (including the neurovasculature) or central circulatory system (including the coronary vasculature).1
References
1. TriSalus™ TriNav® Infusion System, Instructions for Use.